This inventor holds 1 USPTO granted patent. Top assignee: Dupont Pharmaceuticals Company. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Lin Hua Zhang - Innovator in Pharmaceutical Chemistry
Introduction
Lin Hua Zhang is a distinguished inventor based in New Fairfield, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that target platelet aggregation.
Latest Patents
Lin Hua Zhang holds a patent for Crystalline Roxifiban. This potent platelet glycoprotein IIb/IIIa antagonist is produced in crystalline form. Crystalline Roxifiban exists in two polymorphic forms, designated Form 1 and Form 2. These polymorphic forms are characterized by x-ray powder diffraction and solid-state carbon NMR. The patent describes pharmaceutical compositions and methods for the treatment or prevention of diseases mediated by platelet aggregation.
Career Highlights
Lin Hua Zhang is currently associated with Dupont Pharmaceuticals Company, where he continues to advance his research and development efforts. His work has been pivotal in enhancing the understanding of platelet aggregation and its implications in various medical conditions.
Collaborations
Some of his notable coworkers include Michael B Maurin and Philip Ma, who have collaborated with him on various projects within the pharmaceutical domain.
Conclusion
Lin Hua Zhang's innovative work in the field of pharmaceutical chemistry, particularly with Crystalline Roxifiban, showcases his commitment to advancing medical science. His contributions are vital for the development of effective treatments for diseases related to platelet aggregation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile